Prostate Cancer International is
for 2011 by Great NonProfits
A new report from a French research team has provided detailed 5-year data on the oncological outcomes of a series of low- and intermediate-risk prostate cancer patients treated with high-intensity ultrasound (HIFU) using second-generation Ablatherem™ equipment.
Filed under: Management, Treatment, Uncategorized | Tagged: HIFU, high-intensity focused ultrasound, outcome | Leave a Comment »
The potential value of high-intensity focused ultrasound (HIFU) as a treatment for prostate cancer continues to foment controversy between its advocates and its detractors.
Filed under: Management, Treatment | Tagged: HIFU, high-intensity focused ultrasound | Leave a Comment »
High-intensity focused ultrasound (HIFU) continues to gain advocates as a minimally invasive form of treatment for patients with localized and locally advanced prostate cancer, as well as for patients requiring salvage therapy after first-line radiation and after radical prostatectomy.
Filed under: Management, Treatment | Tagged: HIFU, high-intensity focused ultrasound, outcomes | 1 Comment »
The occurrence of bladder outlet obstruction (BOO) as a complication following the use of high-intensity focused ultrasound (HIFU) in the treatment of prostate cancer has been widely recognized since the early, investigational use of HIFU in the 1990s.
Filed under: Management, Treatment | Tagged: bladder neck obstrcution, BOO, HIFU, high-intensity focused ultrasound, transurethral resection, TURP | Leave a Comment »
High-intensity focused ultrasound (HIFU) is legally available in Canada as a method for the treatment of prostate cancer. However, a new Canadian practice guideline states that, “HIFU cannot currently be recommended as an alternative to accepted curative treatment approaches for localized prostate cancer.”
Filed under: Management, Treatment | Tagged: guideline, HIFU, high-intensity focused ultrasound | 2 Comments »
An article still to be formally published in European Urology provides data on the outcomes of 803 patients with localized prostate cancer, all treated with high-intensity focused ultrasound (HIFU) between 1993 and 2007 at six centers in France.
Filed under: Management, Treatment, Uncategorized | Tagged: HIFU, high-intensity focused ultrasound, localized, outcome | 10 Comments »
One of the unknown factors in the use of high-intensity focused ultrasound (HIFU) for the first-line treatment of prostate cancer is the potential for high-quality, biochemical recurrence-free survival over time. Post-treatment histopathology may offer some insight into the likelihood of good outcomes.
Filed under: Management, Treatment | Tagged: HIFU, high-intensity focused ultrasound, histopathology, pathology | 9 Comments »
One of the proposed uses for high-intensity focused ultrasound (HIFU) has been as a treatment option for men with a rising PSA after first-line treatment with external beam radiation therapy (EBRT).
Filed under: Management, Treatment | Tagged: failure, HIFU, high-intensity focused ultrasound, outcome, radiation, salvage | Leave a Comment »
We want to again make the point that treatment of localized prostate cancer with high-intensity focused ultrasound (HIFU), in the hands of inexperienced clinicians, is not necessarily as safe as some of the sales pitches might suggest. In the hands of highly experienced or highly trained HIFU practioners, with access to second- and third-generation equipment, [...]
Filed under: Management, Treatment | Tagged: complications, HIFU, high-intensity focused ultrasound | 2 Comments »
We have learned that last October the “Federaal Kenniscentrum voor de Gezondheidszorg” or KCE in Brussels, Belgium (the “Federal Center for Health Care Knowledge”) published a guidance document on the current use of high-intensity focused ultrasound (HIFU) for the treatment of localized prostate cancer.
Filed under: Management, Treatment | Tagged: Belgium, HIFU, high-intensity focused ultrasound | 4 Comments »
Investigators at Tokai University Hachioji Hospital in Tokyo have been using high-intensity, focused ultrasound (HIFU) to treat men with localized prostate cancer since January 1999. A newly-published paper provides a complete report on this experience.
Filed under: Management, Treatment | Tagged: HIFU, high-intensity focused ultrasound, outcome | Leave a Comment »
The following commentary reports with greater accuracy and in more detail on the same article, dealing with the same series of 172 HIFU patients, as was previously discussed on this web site on July 2 this year. The original report was based solely on the abstract of the article.
Filed under: Management, Treatment | Tagged: HIFU, high-intensity focused ultrasound | 7 Comments »
This initial report contains inaccuracies and is based solely on the abstract of the original paper. A more detailed and accurate assessment of this paper was developed on July 4 after assessment of the complete published paper. Readers are advised to read newer report but you can
Filed under: Management, Treatment | Tagged: HIFU, high-intensity focused ultrasound | 2 Comments »
Recently, a UK-based team (Challacombe et al.) working at a major London teaching hospital reported very poor 2-year follow-up data after treating a series of 31 newly diagnosed and 12 salvage patients with high-intensity focused ultrasound (HIFU) using second-generation Ablatherm equipment. They stated in their original paper that they had suspended their HIFU program as [...]
Filed under: Management, Treatment, Uncategorized | Tagged: HIFU, high-intensity focused ultrasound | 3 Comments »
In today’s news there are reports on: Initial diagnosis of intraductal carcinoma of the prostate An aborted trial of HIFU using the Ablatherm device Late rectal complications after prostate brachytherapy
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: Ablatherm, brachytherapy, carcinoma, complications, HIFU, high-intensity focused ultrasound, intraductal, rectal | Leave a Comment »
Search for new and
ongoing trials on the
CTAG PCa web site